Azienda Ospedaliera Universitaria "Federico II"

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Clinical Assessment of Pharmacokinetics, Efficacy, and Safety of 10% IVIg in Pediatric PID Patients (KIDCARES10)	Blood Protein Disorders, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Primary Immunodeficiency Diseases, agammaglobulinemia, hematologic disorder, hereditary disease, immune system disorder, inborn error of immunity, lymphatic system disorder, lymphoproliferative syndrome	Active, not recruiting	Phase 3	2026-05-29		NCT04944979

Azienda Ospedaliera Universitaria &#34;Federico II&#34;